Depression
Conditions
Keywords
Depression, Perinatal care, Postpartum period, Pregnancy, Female, Low-income population
Brief summary
The study will evaluate the effectiveness of a culturally relevant, multi-component intervention for antenatal depression. The intervention includes an engagement session, and the woman's choice of brief interpersonal psychotherapy and/or pharmacotherapy in a stepped care treatment for depression model.
Detailed description
The randomized control trial will evaluate the effects of a culturally relevant, multi-component intervention for antenatal depression. MOMCare has the potential to overcome patient, provider, and system-level barriers to care and engage depressed, low-income women in evidence-based treatments to reduce antenatal depressive symptoms, improve maternal psychosocial functioning, and ameliorate postpartum depression. Specific Aim 1: To evaluate the impact of MOMCare on treatment engagement and retention. Specific Aim 2: To evaluate the impact of MOMCare on maternal clinical symptoms and functional outcomes. Specific Aim 3: To conduct an incremental cost-effectiveness analysis for a health care and welfare agency perspective that includes a) tracking the medical costs of health service use in MOMCare and usual care patients; b) monitoring the use of infant preventative health services in both groups; and c) tracking the percentage of women on Medicaid and the percentage working in both groups. The intervention will be assessed through a practical randomized controlled trial in which we have recruited 168 pregnant women with major depression and/or dysthymia who were on Medicaid and/or received Maternal Support Services (MSS) in selected public health centers in Seattle - King County (PHSKC). Patients who were eligible and consented to study enrollment were randomly assigned to either usual care (UC) or MOMCare. Baseline and four follow-up assessments (3 - 18 months post-baseline) are scheduled for study participants in both groups. The MOMCare intervention includes a choice of brief interpersonal psychotherapy or collaborative management of antidepressant medication. Treatment response will be monitored, and the treatment will be adjusted as necessary (adding treatments, increasing dosages).
Interventions
8 sessions of brief interpersonal psychotherapy or medication management; maintenance sessions through 12 months postpartum.
Sponsors
Study design
Eligibility
Inclusion criteria
* 18 or older * pregnant: 12-32 weeks gestation * able to speak English * telephone access * major depressive disorder or dysthymia * on Medicaid * receiving health care in King County, Washington
Exclusion criteria
* currently in psychotherapy * currently receiving pharmacotherapy from a psychiatrist * high suicide risk * history of bipolar disorder * history of schizophrenia * substance use or dependence in previous 3 months * currently in a relationship with severe interpersonal violence * history of repetitive self-harm behavior
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SCL-20 depression | baseline, 3, 6 12, 18 month follow-ups |
Secondary
| Measure | Time frame |
|---|---|
| Pregnancy, delivery, birth outcomes | 6 month follow-up |
| Child services & outcomes (immunizations, well-child visits) | 6, 12, 18 month follow-ups |
| Depression free days & Quality Adjusted Life Years (EuroQol) | 3, 6, 12, 18 month follow-ups |
| Quality of depression care process | 3, 6, 12, 18 month follow-ups |
| Maternal health services utilization use and estimated costs | baseline, 3, 6 12, 18 month follow-ups |
| PHQ-9 depression | screening, baseline, 3, 6, 12, 18 month follow-ups |
| Edinburgh Postnatal Depression Scale | baseline, 3, 6, 12, 18 month follow-ups |
| Social Functioning (Work & Social Adjustment, Social & Leisure, Social Support) | baseline, 3, 6, 12, 18 month follow-ups |
| Inventory of Functional Status After Childbirth (IFSAC) | 6, 12, 18 month follow-ups |
| Number of depression treatment sessions attended | 3, 6, 12, 18 month follow-ups |
Countries
United States